NCT07489885

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate to Severe Plaque Psoriasis

• Status: Not Yet Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 75 (estimated)
• Sponsor: InventisBio Co., Ltd · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis

Detailed description

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Participants with Moderate to Severe Plaque Psoriasis

Conditions

• Psoriasis

Interventions

Type	Name	Description
DRUG	D-2570 Tablet	Active Treatment
DRUG	Placebo Tablets	Identical Tablet

Timeline

• Start date: 2026-05-01
• Primary completion: 2027-08-01
• Completion: 2027-12-01
• First posted: 2026-03-24
• Last updated: 2026-03-27

Regulatory

• FDA-regulated drug study